The Bob Harrington Show

A family history of sudden death was the impetus for author Sandeep Juahar's fascination with the heart, which led to a career in cardiology and his latest book Heart: A History.

Fewer black men are going into medicine today than in 1978. Drs Harrington and Capers discuss how to increase diversity in medicine and why it's important for caregivers to reflect the population they treat.

Optimal medical therapy and recent advances show that heart failure is preventable and not obligatory, Clyde Yancy tells Bob Harrington.

It's not all dire. Tait Shanafelt, MD, is witnessing improvement and momentum in the field of clinician wellness. Learn about his journey from hematology to chief wellness officer.

Volunteering at a VA hospital was the first step in biostatistician Frank Harrell's illustrious career in cardiovascular research.

Despite the vastness of available data, don't forget the basics, warns biostatistician Frank Harrell in this conversation with Bob Harrington.

Drs Harrington and Yeh discuss the pros, cons, and cautions of using Twitter in the cardiovascular community.

Drs Harrington and Joynt Maddox discuss the move from volume-based to performance-based payment models and how to develop evidence-based quality metrics that make clinical sense.

Drs Harrington and Gibson discuss burning issues in medicine, including artificial intelligence, social media, wearable tech, and the new hypertension guidelines.

Trials on PCSK9 inhibitors, antiplatelets, anticoagulants, and even catheter ablation of atrial fibrillation are among Drs Harrington and Gibson's picks for what to look for in 2018.

A recent viewpoint by Dr Bhatt against public reporting of PCI outcomes garnered a lot of support in the cardiology community and beyond. Dr Harrington asks how it can be done better.

In this annual tradition, Drs Harrington and Gibson discuss their picks for the top cardiology trials of the year, covering PCSK9 inhibitors, anti-inflammatory and anthithrombotic drugs, and PCI.

Drs Harrington and Kesselheim discuss the varied reasons why prescription drugs are so pricey and whether policies can interrupt this alarming trend.

Dr Califf talks about his new role at Verily and how data mining and data sharing could reduce disparities in care and improve patient outcomes.

From being critiqued by Bernie Sanders to the controversial Duchenne drug approval decision, Dr Califf recounts his experiences as FDA commissioner.

The Veterans Health Administration is the largest integrated healthcare system in the US with a common EHR. Dr Harrington learns the advantages for cardiology practice and research.

Why are only 13% of cardiologists women? Drs Harrington and Duvernoy discuss results from the recent ACC lifestyle survey and strategies for making cardiology 'a more human place.'

Drs Harrington and Douglas discuss pay disparities for women in cardiology and the importance of leveling the playing field.

Drs Harrington and Butte discuss the overwhelming amount of data generated in contemporary healthcare and how it can be harnessed to deliver precision medicine.

Drs Harrington and Gibson give their annual review of the highs and lows in medicine with a focus on cardiology.

Dr Harrington interviews Dr John Brush about his exploration of cognitive psychology (behavioral economics) and how it can improve physician decision-making.

Dr Harrington interviews HEAT-PPCI principal investigator Dr Rod Stables about engaging the hospital community in research and the benefits for all concerned.

No Luddite, Dr Wachter thinks digital medicine is a good thing if we can learn from aviation and develop technology that better serves patients and healthcare providers.

Drs Harrington and Hernandez discuss the limitations of randomized trials and the upcoming ADAPTABLE trial on aspirin dosing developed under the patient-centered-outcomes research initiative from NIH.

Euan Ashley, self-described geek-turned-cardiologist, discusses how big data can help you practice smarter medicine.